News

Net loss of Fischer Medical Ventures reported to Rs 7.10 crore in the quarter ended March 2026 as against net profit of Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 98.76% to Rs 97.73 crore in the quarter ended March 2026 as against Rs 49.17 crore during the previous quarter ended March 2025.For the full year,net profit rose 2463.64% to Rs 31.02 crore in the year ended March 2026 as against Rs 1.21 crore during the previous year ended March 2025. Sales rose 178.75% to Rs 308.58 crore in the year ended March 2026 as against Rs 110.70 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales97.7349.17 99 308.58110.70 179 OPM %1.025.08 -13.963.00 - PBDT-1.332.43 PL 49.564.34 1042 PBT-2.251.92 PL 46.582.71 1619 NP-7.101.31 PL 31.021.21 2464 Powered by Capital Market - Live News

Fischer Medical Ventures announced that the Board of Directors of the Company at its meeting held on 29 May 2026, inter alia, have recommended the final dividend of Rs 0.05 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Fischer Medical Ventures reported to Rs 19.23 crore in the quarter ended December 2025 as against net loss of Rs 0.29 crore during the previous quarter ended December 2024. Sales rose 760.43% to Rs 101.10 crore in the quarter ended December 2025 as against Rs 11.75 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales101.1011.75 760 OPM %21.283.15 - PBDT21.960.68 3129 PBT21.190.12 17558 NP19.23-0.29 LP Powered by Capital Market - Live News

Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live News